Professor Ulrike Nowak-Göttl, Department of Paediatric Haematology and Oncology, University Hospital of Münster, Germany, and colleagues did a study of 396 children who had suffered a first cerebral venous thrombosis (CVT/stroke), and monitored them for an average of 36 months to determine the risk of a second cerebral or systemic venous thrombosis. The study is the largest and longest follow-up study of children with a first onset of stroke.
They found that 12 of the children died immediately, while 22 had recurrent VT, of which 13 were cerebral. Recurrent VT only occurred in children over two-years-old, and children who did not receive anti-coagulant drugs were 11 times for likely to have recurrent VT. Children suffering from venous occlusion (blocking of the veins to any blood flow) were over four times more likely to have recurrent VT, as were children with a genetic mutation already known to increase risk of VT.
The authors say: “Although cerebral venous thrombosis is associated with substantial mortality and morbidity, its causes in children have not been extensively investigated.”
Children older than two years who had a second VT did so at an average age of 13 years – the authors propose that this is because after the high risk first year of life, the next highest risk period of a child’s life relating to VT is puberty, probably due to hormonal changes and the down-regulation of the fibrinolytic system. This finding is backed by previous studies.
However the authors caution that continued use of anticoagulants in children has to be balanced against the risks of them suffering haemorrhages due to being physically active, and each case has to be considered individually. Where the risk of repeated VT is high, the benefit of anticoagulant therapy could clearly outweigh the risk of possible haemorrhage.
The authors conclude by calling for larger randomised studies into repeated VTs. They say: “Until data from such studies are available, the message of this follow-up study is clearly that administration of secondary anticoagulation prophylaxis should be considered on an individual patient basis in children with newly identified CVT in situations where the risk of VT is high.”
In an accompanying Comment, Dr Meredith Golomb, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, USA, says: “Recurrent venous thromboembolism after cerebral sinovenous thrombosis can be devastating.”
She then asks: “Which patients absolutely need to be on anticoagulation, and which ones can be safely weaned off? How can we tell the parents of an otherwise healthy five-year-old that he can never sled, perform gymnastics, or wrestle with his siblings? What doses of anticoagulation will keep the risk of recurrence and bleeding to a minimum?”
She concludes: “This paper provides some important answers; however, physicians, patients, and the patients’ families have many more questions.”
Tony Kirby | alfa
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy